Morningstar7d
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
The approval of exenatide 1.2 mL and 2.4 mL prefilled pen injection, referencing BYETTA®, reflects the Company’s deep innovation and regulatory capabilities in complex pharmaceuticals and its ...